Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 57

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 57
---
, you will likely not be able to exercise your
redemption rights.

<div align='center'>36

PROPOSAL 1: THE EXTENSION AMENDMENT PROPOSAL</div>

Overview

The Company is proposing
to amend its currently effective M&A to extend the date by which the Company has to consummate a Business Combination to the Extended
Date so as to give the Company additional time to complete the Business Combination. The proposed Extension Amendment would amend by special
resolution the Company’s M&A to extend the date by which the Company would be required to consummate an initial business combination
from December 15, 2025 to March 16, 2026 (or such earlier date as determined by the Board in its sole discretion). The complete
text of the proposed amendment is attached to this proxy statement as Annex A. All shareholders are encouraged to read the proposed amendment
in its entirety for a more complete description of its terms.

A copy of the proposed Extension
Amendment is attached to this proxy statement as Annex A.

Without the Extension, the
Board believes that there is significant risk that the Company might not, despite its best efforts, be able to complete an initial business
combination on or before the Termination Date. If that were to occur, the Company would be precluded from completing the Btab Business
Combination or another Business Combination and would be forced to liquidate even if the Company’s shareholders are otherwise in
favor of consummating such transaction.

As contemplated by the M&A,
the holders of Public Shares may elect to redeem all or a portion of their Public Shares in exchange for their pro rata portion of the
funds held in the Trust Account if the Extension Amendment is approved.

The Company estimates that
the per-share pro rata portion of the Trust Account will be approximately $[ ] at the time of the Meeting (including accrued interest
and less taxes paid or payable). The closing price of the Company’s Class A ordinary shares on OTC Pink Limited Market (“OTC Markets”) on [ ], 2025 was $[ ]. Accordingly, if the market price were to remain the same until the date of the Meeting, exercising
redemption rights would result in a public shareholder receiving $[ ] less for each share than if such shareholder sold the shares in
the open market. The Company cannot assure shareholders that they will be able to sell their public shares in the open market, even if
the market price per share is higher than the redemption price stated above, as